New nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval

By Associated Press

May 24, 2023 12:17 am

(UPDATE) WASHINGTON, D.C.: US health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl and other opioids driving the nation's drug crisis.

Opvee is similar to naloxone, the life-saving drug that has been used for decades to quickly counter overdoses of heroin, fentanyl and prescription painkillers. Both work by blocking the effects of opioids in the brain, which can restore normal breathing and blood pressure in people who have recently overdosed.

ANTIDOTE This photo provided by Indivior in May 2023 shows their drug opvee. On Monday, May 22, 2023, US health regulators approved the medication to reverse overdoses caused by fentanyl and other powerful opioids, which are currently driving the nation’s drug crisis. AP PHOTO

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

DeepSeek's blockbuster chatbot to Chinese telecom banned from doing business in US

Nissan calls off Honda merger talks

Toyota raises full-year profit outlook by 9%

Pfizer earnings exceed estimates

Estee Lauder to cut up to 7,000 jobs

Google parent plans massive capex hike

Ferrari races to record-breaking year